Related Experiment Video
Updated: Jan 27, 2026

Author Spotlight: Advancing Diabetes Research with Static Exercise Training in Mice
Published on: March 29, 2024
Corrections to: Achieving Glycaemic Control with Concentrated Insulin in Patients with Type 2 Diabetes
Sudesna Chatterjee1,2, Kamlesh Khunti3, Melanie J Davies3
1University Hospitals of Leicester NHS Trust, Senior Clinical Researcher, University of Leicester, Leicester, UK. Sudesna.chatterjee@abbott.com.
Abstract:
In several sections of this review article, insulin degludec U100 has been incorrectly referred to as a highly concentrated basal insulin. Although data for both the U100 and U200 formulations of insulin degludec are presented, only insulin degludec U200 and insulin glargine U300 should be referred to as highly concentrated basal insulins.
More Related Videos
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Distance Corrections
Power Factor Correction

